The Hims & Hers wellness platform announced Wednesday it will soon offer a generic version of the weight loss drug ...

Wegovy® is indicated for chronic weight management in adults and adolescents (12+) with obesity or overweight and at least ...

The investigational dual GLP-1 and amylin receptor agonist Amycretin demonstrated significant weight loss-up to 24% with ...

Already a household name in diabetes and weight management, Ozempic (semaglutide) may soon find another surprising role — as ...

They were designed to treat diabetes, then prescribed for weight loss, and now—as researchers are finding—they might hold the ...

Interpol cited a concerning rise in demand for unauthorised weight loss drugs and peptide supplements in Europe and other ...

The Dalai Lama said on Wednesday the institution of the Dalai Lama will continue and the Gaden Phodrang trust has sole ...

A recent study suggests that liraglutide, a drug similar to Ozempic, may reduce migraine frequency in obese individuals with chronic migraines. Participants experienced nearly a 50% reduction in ...

These six stocks span numerous sectors, providing investors with opportunities in both growth and dividend yield.

The drugmaker has become a clear winner with its weight-loss drugs. Now, with a pill under development, the company should ...

In addition to its licensing deals, the Denmark-based drugmaker has promising ... the company asked the U.S. Food and Drug Administration to approve an oral formulation of semaglutide (the active ...

Semaglutide — the active ingredient in Ozempic®, Wegovy®, and Rybelsus® — can reduce your appetite and curb food cravings to promote weight loss.